Serum levels of tumor necrosis factor-α are increased in obese patients with noninsulin-dependent diabetes mellitus

Journal of Clinical Endocrinology and Metabolism

Volumn 83, Issue 3, 1998, Pages 859-862

  Katsuki, Akira ^a   Sumida, Yasuhiro ^a   Murashima, Shuichi ^a   Murata, Kazuya ^b   Takarada, Yoshihiro ^b   Ito, Kuninobu ^a   Fujii, Masashi ^a   Tsuchihashi, Ken ^a   Goto, Hiroyuki ^a   Nakatani, Kaname ^a   Yano, Yutaka ^a  

^a MIE UNIVERSITY   (Japan)

^b ISE RED CROSS HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BODY FAT; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORRELATION FUNCTION; FEMALE; HUMAN; INSULIN RESISTANCE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL;

ADIPOSE TISSUE; DIABETES COMPLICATIONS; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE; GLUCOSE CLAMP TECHNIQUE; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; OBESITY; REFERENCE VALUES; TOMOGRAPHY, X-RAY COMPUTED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 15644362064     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.83.3.859     Document Type: Article

References (23)

1. Moller DE, Flier JS. 1991 Insulin resistance-mechanisms, syndromes, and implications. N Engl J Med. 211:938-948.
2. Hotamisligil GS, Spiegelman BM. 1994 Tumor necrosis factor-α: a key component of the obesity-diabetes link. Diabetes. 43:1271-1278.
3. Hotamisligil GS, Shargill NS, Spiegelman BM. 1993 Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance. Science. 259:87-91.
4. Feinatein R, Kanety H, Papa MZ, Lunenfeld B, Karasik A. 1993 Tumor necrosis factor-α suppresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrates. J Biol Chem. 268:26055-26058.
5. Kern PA, Saghizadeh M, Ong JM, Bosch RJ, Deem R, Simsolo RB. 1995 The expression of tumor necrosis factor in human adipose tissue, regulation by obesity, weight loss, and relationship to lipoprotein lipase. J Clin Invest. 95:2111-2119.
6. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. 1995 Increased adipose tissue expression of tumor necrosis factor-α in human obesity and insulin resistance. J Clin Invest. 95:2409-2415.
7. Tokunaga K, Matsuzawa Y, Ishikawa K, Tarui S. 1983 A novel technique for the determination of body fat by computed tomography. Int J Obesity. 7:437-445.
8. DeFronzo RA, Tobin JD, Andres R. 1979 Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 237:E214-223.
9. Kissebah AH, Vydelingum N, Murray R, et al. 1982 Relation of body fat distribution to metabolic complications of obesity. J Clin Endocrinol Metab. 54:254-260.
10. Fujioka S, Matsuzawa Y, Tokunaga K, Tarui S. 1987 Contribution of intraabdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity. Metabolism. 36:54-59.
11. Morohoshi M, Fujisawa k, Uchimura I, Numano F. 1996 Glucose-dependent interleukin 6 and tumor necrosis factor production by human peripheral blood monocytes in vitro. Diabetes. 45:954-959.
12. Ohno Y, Aoki N, Nishimura A. 1993 In vitro production of interleukin-1, interleukin-6, and tumor necrosis factor-α in insulin-dependent diabetes mellitus. J Clin Endocrinol Metab. 77:1072-1077.
13. Ling PR, Bistrian BR, Mendez B, Istfan NW. 1994 Effects of infusions of endotoxin, tumor necrosis factor, and interleukin-1 on glucose metabolism in the rat: relationship to endogenous glucose production and peripheral tissue glucose uptake. Metabolism. 43:279-284.
14. Lang CH, Dobrescu C, Bagby GJ. 1992 Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic glucose output. Endocrinology. 130:43-52.
15. Hotamisligil GS, Budavari A, Murray D, Spiegelman BM. 1994 Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. J Clin Invest. 94:1543-1549.
16. Hotamisligil GS, Murray DL, Choy LN, Spiegelman BM. 1994 Tumor necrosis factor-α inhibits signaling from the insulin receptor. Proc Natl Acad Sci USA. 91:4854-4858.
17. Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, Spiegelman BM. 1996 IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-α- and obesity-induced insulin resistance. Science. 271:665-668.
18. Begum N, Ragolia L. 1996 Effect of tumor necrosis factor-α on insulin action in cultured rat skeletal muscle cells. Endocrinology. 137:2441-2446.
19. Kanety H, Hemi R, Papa MZ, Karasik A. 1996 Sphingomyelinase and ceramide suppress insulin-induced tyrosine phosphorylation of the insulin receptor substrate-1. J Biol Chem. 271:9895-9897.
20. Szalkowski D, White-Carrington S, Berger J, Zhang B. 1995 Antidiabetic thiazolidines block the inhibitory effect of tumor necrosis factor-α on differentiation, insulin stimulated glucose uptake, and gene expression in 3T3-L1 cells. Endocrinology. 136:1474-1481.
21. Hauner H, Petruschke Th, Russ M, Rohrig K, Eckel J. 1995 Effects of tumor necrosis factor-alpha (TNF-α) on glucose transport and lipid metabolism of newly-differentiated human fat cells in cell culture. Diabetologia 38:764-771.
22. Saghizadeh M, Ong JM, Garvey WT, Henry RR, Kern PA. 1996 The expression of TNF α by human muscle, relationship to insulin resistance. J Clin Invest. 97:1111-1116.
23. Kroder G, Bossenmainer B, Kellerer M, et al. 1996 Tumor necrosis factor-α and hyperglycemia-induced insulin resistance, evidence for different mechanisms and different effects on insulin signaling. J Clin Invest. 97:1471-1477.